CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-19 | Pang Phillip Chief Medical Officer | Option exercise | +2,315 | $5.18 | $12K | 28,277 |
| 2020-08-19 | Pang Phillip Chief Medical Officer | Option exercise | +14,000 | $0.86 | $12K | 42,277 |
| 2020-08-19 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $50.96 | $255K | 37,277 |
| 2020-08-19 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $50.94 | $382K | 29,777 |
| 2020-08-19 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,185 | 75,462 | ||
| 2020-08-19 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 71,759 | ||
| 2020-08-19 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −14,000 | 81,333 | ||
| 2020-08-11 | Virgin Herbert EVP, Research & CSO | Option exercise | +7,900 | $1.53 | $12K | 7,900 |
| 2020-08-11 | Virgin Herbert EVP, Research & CSO | Sale | −7,900 | $51.08 | $404K | 0 |
| 2020-08-11 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −7,900 | 500,255 | ||
| 2020-08-05 | Pang Phillip Chief Medical Officer | Option exercise | +12,500 | $1.58 | $20K | 28,277 |
| 2020-08-05 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $50.91 | $255K | 23,277 |
| 2020-08-05 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $50.89 | $382K | 15,777 |
| 2020-08-05 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 85,647 | ||
| 2020-08-03 | Parrish Jay Chief Business Officer | Option exercise | +9,259 | $1.49 | $14K | 231,481 |
| 2020-08-03 | Parrish Jay Chief Business Officer | Option exercise | +1,851 | $1.58 | $3K | 233,332 |
| 2020-08-03 | Parrish Jay Chief Business Officer | Sale | −11,110 | $47.65 | $529K | 222,222 |
| 2020-08-03 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −9,259 | 37,037 | ||
| 2020-08-03 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −1,851 | 60,184 | ||
| 2020-07-30 | Rice Steven J. Chief Administrative Officer | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 52 of 54 · 1,063 trades